Friday, 19 September 2014

Effects of telecare intervention for glycemic control in Type 2 Diabetes: A systematic review and meta-analysis of randomized controlled trials

Patients monitored by telecare showed significant improvement in glycemic control in type 2 diabetes than those monitored by routine follow-up (European Society of Endocrinology)


FDA Approves Trulicity™ (dulaglutide), Lilly's Once-Weekly Therapy for Adults with Type 2 Diabetes

Trulicity is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes (Lilly)


Xultophy® (IDegLira) approved in Europe

Xultophy® is for the treatment of type 2 diabetes mellitus in adults. The authorisation covers all 27 European Union member states. Press release (Novo Nordisk)

No comments:

Post a Comment